SNT 2.22% 4.4¢ syntara limited

Ann: Pharmaxis Announces LOXL2 Program Phase 2 Ready, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. eer
    812 Posts.
    lightbulb Created with Sketch. 5

    Only a matter of weeks now...ready for phase 2 will be a point big pharma knows is value for them long term.

    They have to look in the locker and decide if they have a better option. There are compelling facts to suggest a few need this in there stable so I think we will be over the line in weeks not months.

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.